Skip to main content

Peer Review reports

From: Prognostic markers in patients with chronic lymphocytic leukaemia on targeted therapy, chemoimmunotherapy with anti-CD20 monoclonal antibody: a systematic review and meta-analysis of prognostic factors

Original Submission
30 Apr 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
24 Jun 2022 Reviewed Reviewer Report - Lina Van Der Straten
29 Jun 2022 Reviewed Reviewer Report
25 Aug 2022 Author responded Author comments - Bongani B. Nkambule
Resubmission - Version 4
25 Aug 2022 Submitted Manuscript version 4
4 Sep 2022 Author responded Author comments - Bongani B. Nkambule
Resubmission - Version 5
4 Sep 2022 Submitted Manuscript version 5
14 Sep 2022 Author responded Author comments - Bongani B. Nkambule
Resubmission - Version 6
14 Sep 2022 Submitted Manuscript version 6
18 Sep 2022 Reviewed Reviewer Report
22 Sep 2022 Reviewed Reviewer Report - Lina Van Der Straten
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
4 Oct 2022 Editorially accepted
25 Nov 2022 Article published 10.1186/s12885-022-10223-0

You can find further information about peer review here.

Back to article page